Searched for
RAGHAV CHARI
Meet India's brightest young minds: Forbes unveils '30 under 30' Asia listForbes recently unveiled its 9th edition of the "30 Under 30 Asia" list, showcasing young leaders and innovators under 30 across the Asia-P...- Buy Dr. Reddy's Laboratories, target Rs 2715.0 : Siddharth BhamreBuy Dr. Reddy's Laboratories Ltd. at a price target of Rs 2715.0 and a stop loss at Rs 2560.0 from entry point
- Sell Dr. Reddy's Laboratories, target Rs 2577.0 : Deen Dayal InvestmentSell Dr. Reddy's Laboratories Ltd. at a price target of Rs 2577.0 and a stop loss at Rs 2650 from entry point
- Dr Reddy's launches Sernivo spray in the US marketThis adds to another milestone for the Promius Pharma, committed to develop innovative treatment options in dermatology space, spray to be ...
- Dr Reddy's migraine injection enters US marketDr Reddy's Laboratories (DRL) today said its acute migraine treatment injection ZembraceSymTouch is now commercially available in the US ma...
- Dr Reddy's Laboratories, Japan's Eisai ink licensing pact for anticancer agentIn exchange, Eisai will receive milestone payments in line with obtaining marketing approval and the achievement of agreed upon sales targe...
- Dr Reddy’s Laboratories inks US licensing pact with XenoPortDr Reddy’s Laboratories will pay an upfront fee of $50 million to XenoPort and up to $440 million on achievement of certain milestones.
- Dr Reddy's signs US licensing agreement with XenoPortDr Reddy's Laboratories said it is planning to develop XP23829 as a potential treatment for moderate-to-severe chronic plaque psoriasis.
- Dr Reddy's Laboratories gets USFDA approval to market Sernivo sprayThe company said its US subsidiary Promius Pharma has received USFDA approval to market Sernivo spray, used in treatment of skin disorder.
- Dr Reddy’s goes beyond generic products, gets nod for two branded drugsThe approvals have come at a time when Indian drug companies are facing the FDA’s ire for non-compliance of good manufacturing process.
- Dr Reddy's Laboratories gets tentative approval from USFDA for ZenavodPromius Pharma LLC, the company's US arm will be responsible for commercialising Zenavod in the US market, it added.
- Dr Reddy's gets USFDA nod for migraine injectionThe company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in a stateme...
- Dr Reddy's files three new drug applications with USFDAOf them, the two NDAs are the first dermatology applications submitted to the US regulator that were fully developed leveraging in-house ca...
- Ajay Banga, Salman Rushdie win Remit2India's 'Light of India' awards for 2011Winners for Light of India jury awards were Ajay Banga, Vinod Khosla, Ruby Dhalla, Mira Nair, Chitra Divakaruni and Vinod Dham.
- Remit2India 'The Light of India Awards' 2011 winners announcedLight of India Awards is an initiative of Remit2India to honor the Indians abroad who have risen to global stage. Winners were announced in...
Load More
